1. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator—the EVADEF study Eloi Marijon, MD, Ludovic Trinquart, MSc, Akli Otmani, MD, Christophe Leclercq, MD, PhD, Laurent Fauchier, MD, PhD, Philippe Chevalier, MD, PhD, Didier Klug, MD, Pascal Defaye, MD, Nicolas Lellouche, MD, Jacques Mansourati, MD, Jean-Claude Deharo, MD, Nicolas Sadoul, MD, Frédéric Anselme, MD, Philippe Maury, MD, Jean-Marc Davy, MD, PhD, Fabrice Extramiana, MD, PhD, Françoise Hidden-Lucet, MD, Vincent Probst, MD, PhD, Pierre Bordachar, MD, Hassan Mansour, MD, Michel Chauvin, MD, Xavier Jouven, MD, PhD, Thomas Lavergne, MD, Gilles Chatellier, MD, PhD, Jean-Yves Le Heuzey, MD American Heart Journal Volume 159, Issue 4, Pages 659-664.e1 (April 2010) DOI: 10.1016/j.ahj.2010.01.011 Copyright © 2010 Mosby, Inc. Terms and Conditions Terms and Conditions

2. Figure 1 American Heart Journal 2010 159, 659-664.e1DOI: (10.1016/j.ahj.2010.01.011) Copyright © 2010 Mosby, Inc. Terms and Conditions Terms and Conditions

3. Figure 2 American Heart Journal 2010 159, 659-664.e1DOI: (10.1016/j.ahj.2010.01.011) Copyright © 2010 Mosby, Inc. Terms and Conditions Terms and Conditions